EUVIMEDEUVIMED entdecken
Crossref

Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing

Clara Diaz Garcia-Prada, Salima Atis, Jean-Pierre Pouget, Julie Constanzo

Methods in Cell Biology · 2025

DOI: 10.1016/bs.mcb.2024.05.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Cell Biology, 2025. Verfasst von Clara Diaz Garcia-Prada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM…. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Radioimmunotherapy, Ovarian Neoplasms. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Institut National Du Cancer, Labex, Laboratoire d'Excellence MAbImprove.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, Ovarian Cancer (OC) is the most lethal gynecological malignancy. In most patients, it progresses without clinical signs or symptoms, leading to a late diagnosis when it has already spread in the peritoneal cavity as peritoneal carcinomatosis (PC). To date, OC PC management is based on cytoreductive surgery to remove the macroscopic disease, followed by chemotherapy. Many patients respond to this treatment, but disease recurs in 70-90% of them. Therefore, new therapeutic approaches are needed. The field of targeted radionuclide therapy (TRT) has witnessed considerable progress and several radiopharmaceuticals have been approved in the last decade. In TRT, radiolabeled molecules are injected to specifically recognize, irradiate, and kill tumor cells. TRT is a multisite radiotherapy that delivers dose to all malignant lesions. Therefore, TRT could be an alternative approach for OC PC because conventional external beam radiotherapy cannot be used at curative dose due to toxicity to healthy tissues. Here, we describe an OC PC model based on grafting human SK-OV-3 OC cells in the peritoneal cavity of immunodeficient mice. We also explain how to label trastuzumab with lutetium-177 to specifically target and irradiate SK-OV-3 cell nodules in these mice, and how to monitor the response to this TRT in vivo. With minor variations, the same technique can be conveniently applied to a variety of human (or mouse) tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsRadioimmunotherapyOvarian NeoplasmsFemaleAnimalsHumansMiceCell Line, TumorXenograft Model Antitumor AssaysDisease Models, AnimalRadiopharmaceuticalsRadioisotopes

Stichwörter der Autor:innen

Epithelial ovarian cancerHGSOCRadiopharmaceuticalsTargeted radionuclide therapy

Substanzen

RadiopharmaceuticalsRadioisotopes

Autor:innen und Institutionen

  • Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.
  • Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France. Electronic address: jean-pierre.pouget@inserm.…
  • Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France. Electronic address: julie.constanzo@inserm.fr.

Förderung

  • Institut National Du Cancer
  • Labex
  • Laboratoire d'Excellence MAbImprove
  • Fondation ARC pour la Recherche sur le Cancer
  • Ligue Contre le Cancer

Zitieren

APA

Diaz Garcia-Prada, C., Atis, S., Pouget, J. P., & Constanzo, J. (2025). Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2024.05.013

Vancouver

Diaz Garcia-Prada C, Atis S, Pouget JP, Constanzo J. Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing. Methods in Cell Biology. 2025. doi:10.1016/bs.mcb.2024.05.013

BibTeX
@article{DiazGarciaPrada2025,
  author = {Diaz Garcia-Prada, Clara and Atis, Salima and Pouget, Jean-Pierre and Constanzo, Julie},
  title = {Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing},
  journal = {Methods in Cell Biology},
  year = {2025},
  doi = {10.1016/bs.mcb.2024.05.013}
}
Kostenlos starten →